US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tectonic Therapeutic, Inc.

18.65

-0.2600-1.37%

Volume:156.81K

Turnover:2.92M

Market Cap:348.06M

PE:-5.14

High:19.14

Open:18.69

Low:18.29

Close:18.91

Loading ...

Overview Company News Filings

Tectonic Therapeutic Up Over 99%, on Pace for Record Percent Increase -- Data Talk

Dow Jumps Over 100 Points; Tesla Earnings Miss Views

Tectonic Therapeutic Shares Soar Pre-Bell Following Interim Data From TX45 Trial

MT Newswires Live

Tectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45

Tectonic Therapeutic Inc - Tx45 Well Tolerated With No Serious Adverse Events in Ph-Hfpef

THOMSON REUTERS

Tectonic Therapeutic Announces Positive Interim Data From Phase 1B Trial for Tx45 in Patients With Group 2 Pulmonary Hypertension in Hfpef

THOMSON REUTERS

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

Tectonic Therapeutic Down Over 36%, on Pace for Largest Percent Decrease Since January 2022 -- Data Talk

Tectonic Therapeutic Inc trading resumes

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

Raymond James Initiates Tectonic Therapeutic at Outperform

MT Newswires Live

Tectonic Therapeutic Inc : Raymond James Initiates Coverage With Outperform Rating; Target Price $65

THOMSON REUTERS

Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks

Tectonic Therapeutic Inc. Reports Q3 2024 Results

Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/TECX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TECX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TECX\",,,,,undefined,":{"symbol":"TECX","market":"US","secType":"STK","nameCN":"Tectonic Therapeutic, Inc.","latestPrice":18.65,"timestamp":1743192000000,"preClose":18.91,"halted":0,"volume":156808,"delay":0,"floatShares":9328300,"shares":18662672,"eps":-3.626985,"marketStatus":"Pre-Market Trading","change":-0.26,"latestTime":"03-31 08:36:04 EDT","open":18.69,"high":19.14,"low":18.29,"amount":2917305.112904,"amplitude":0.04495,"askPrice":21.71,"askSize":100,"bidPrice":14.66,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.626985,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743427800000},"marketStatusCode":1,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":18.65,"postHourTrading":{"tag":"盘后","latestPrice":18.65,"preClose":18.65,"latestTime":"19:14 EDT","volume":2386,"amount":44504.48,"timestamp":1743203648033},"volumeRatio":0.4838510605281423},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TECX\",,,,,undefined,":{"symbol":"TECX","floatShares":9328300,"roa":"-37.71%","roe":"-84.79%","lyrEps":-16.256264,"volumeRatio":0.4838510605281423,"shares":18662672,"dividePrice":0,"high":19.14,"amplitude":0.04495,"preClose":18.91,"low":18.29,"week52Low":14.04,"pbRate":"2.47","week52High":61.07,"institutionHeld":0,"latestPrice":18.65,"eps":-3.626985,"divideRate":0,"volume":156808,"delay":0,"ttmEps":-3.626985,"open":18.69,"prevYearClose":46.17,"prevWeekClose":18.65,"prevMonthClose":25.28,"prevQuarterClose":46.17,"fiveDayClose":21.15,"twentyDayClose":25.28,"sixtyDayClose":46.79},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TECX\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507627177","title":"Tectonic Therapeutic Up Over 99%, on Pace for Record Percent Increase -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2507627177","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507627177?lang=en_us&edition=fundamental","pubTime":"2025-01-30 23:35","pubTimestamp":1738251300,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc  is currently at $51.26, up $25.54 or 99.3%. --Would be highest close since Dec. 6, 2024, when it closed at $51.47. --Currently up two consecutive days; up 109.74% over this period. --Up 11.02% month-to-date; on pace for best month since Nov. 2024, when it rose 21.33%. --Down 91.89% from its all-time closing high of $632.40 on Sept. 26, 2018. --Up 236.35% from 52 weeks ago , when it closed at $15.24. --Up 260.48% from its 52-week closing low of $14.22 on April 25, 2024. --Traded as high as $55.80; highest intraday level since Nov. 24, 2021, when it hit $60.84. --Up 116.95% at today's intraday high; largest intraday percent increase since May 22, 2023, when it rose as much as 119.33%","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Tectonic Therapeutic Up Over 99%, on Pace for Record Percent Increase -- Data Talk","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2507249406","title":"Dow Jumps Over 100 Points; Tesla Earnings Miss Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2507249406","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507249406?lang=en_us&edition=fundamental","pubTime":"2025-01-30 23:03","pubTimestamp":1738249415,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/01/43340053/dow-jumps-over-100-points-tesla-earnings-miss-views","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATHE","SLXN","TSLL","TSLA","CRGX","AMOD","TECX","PCOM","CLEU"],"gpt_icon":1},{"id":"2507267856","title":"Tectonic Therapeutic Shares Soar Pre-Bell Following Interim Data From TX45 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2507267856","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507267856?lang=en_us&edition=fundamental","pubTime":"2025-01-30 22:18","pubTimestamp":1738246732,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic  shares climbed 90% in Thursday's premarket session after the company said a phase 1b trial showed that TX45 improved left ventricular function and pulmonary hemodynamics.The biotech firm said TX45 was well tolerated with no serious or severe adverse events, discontinuations, infusion reactions, or drug-related adverse events.\"These interim results show that TX45 achieved improvements in hemodynamics which met and exceeded our prespecified objectives,\" Chief Executive Alise Reicin said in a release.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2507644882","title":"Tectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45","url":"https://stock-news.laohu8.com/highlight/detail?id=2507644882","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507644882?lang=en_us&edition=fundamental","pubTime":"2025-01-30 19:41","pubTimestamp":1738237295,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic (TECX) announced positive interim data from the Phase 1b acute hemodynamic clinical trial of its lead product candidate, TX45,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tectonic-therapeutic-reports-positive-data-from-phase-1b-trial-for-tx45?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tectonic-therapeutic-reports-positive-data-from-phase-1b-trial-for-tx45?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2507641649","title":"Tectonic Therapeutic Inc - Tx45 Well Tolerated With No Serious Adverse Events in Ph-Hfpef","url":"https://stock-news.laohu8.com/highlight/detail?id=2507641649","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507641649?lang=en_us&edition=fundamental","pubTime":"2025-01-30 19:30","pubTimestamp":1738236600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA2SKMGT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2507164134","title":"Tectonic Therapeutic Announces Positive Interim Data From Phase 1B Trial for Tx45 in Patients With Group 2 Pulmonary Hypertension in Hfpef","url":"https://stock-news.laohu8.com/highlight/detail?id=2507164134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507164134?lang=en_us&edition=fundamental","pubTime":"2025-01-30 19:30","pubTimestamp":1738236600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA2SKMGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2507262641","title":"Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF","url":"https://stock-news.laohu8.com/highlight/detail?id=2507262641","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507262641?lang=en_us&edition=fundamental","pubTime":"2025-01-30 19:30","pubTimestamp":1738236600,"startTime":"0","endTime":"0","summary":"TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”), supporting endpoi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/30/3017839/0/en/Tectonic-Therapeutic-Announces-Positive-Interim-Data-from-Phase-1b-Trial-for-TX45-in-Patients-with-Group-2-Pulmonary-Hypertension-in-HFpEF.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2507952539","title":"Tectonic Therapeutic Down Over 36%, on Pace for Largest Percent Decrease Since January 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2507952539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507952539?lang=en_us&edition=fundamental","pubTime":"2025-01-29 04:37","pubTimestamp":1738096620,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc  is currently at $26.28, down $14.90 or 36.18%. --Would be lowest close since Sept. 24, 2024, when it closed at $24.24. --On pace for largest percent decrease since Jan. 4, 2022, when it fell 36.63%. --Currently down two consecutive days; down 43.77% over this period. --Down 95.84% from its all-time closing high of $632.40 on Sept. 26, 2018. --Up 90.43% from 52 weeks ago , when it closed at $13.80. --Up 90.43% from its 52-week closing low of $13.80 on Jan. 30, 2024. --Traded as low as $15.30; lowest intraday level since July 5, 2024, when it hit $15.08. --Down 62.85% at today's intraday low; largest intraday percent decrease on record ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2507542880","title":"Tectonic Therapeutic Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2507542880","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507542880?lang=en_us&edition=fundamental","pubTime":"2025-01-29 02:25","pubTimestamp":1738088718,"startTime":"0","endTime":"0","summary":"13:22 EST Tectonic Therapeutic (TECX) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tectonic-therapeutic-inc-trading-resumes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tectonic-therapeutic-inc-trading-resumes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2488765219","title":"Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2488765219","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488765219?lang=en_us&edition=fundamental","pubTime":"2024-12-04 05:01","pubTimestamp":1733259660,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Dec.  03, 2024  (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”) a clinical stage biotechnology company focused on the discovery and development of therapeu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/03/2991046/0/en/Tectonic-Therapeutic-to-Host-KOL-Event-on-the-Unmet-Need-in-Group-2-PH-HFpEF-and-TX45-as-a-Potential-Treatment-on-Thursday-December-12-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","LU0070302665.USD","TECX","HST","BK4588","KOL","LU1989772840.SGD","LU0211331839.USD","BK4580","LU0320765489.SGD","PH","LU0256863902.USD","BK4181","BK4139","BK4218","LU1989772923.USD","BK4161","LU0256863811.USD","LU0417517546.SGD","BK4585"],"gpt_icon":0},{"id":"2486831128","title":"Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2486831128","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486831128?lang=en_us&edition=fundamental","pubTime":"2024-11-27 05:01","pubTimestamp":1732654860,"startTime":"0","endTime":"0","summary":"Dan Ferry. LifeSci Advisors. (617) 430-7576. Media:. Kathryn Morris. The Yates Network. (914) 204-6412","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/26/2987803/0/en/Tectonic-Therapeutic-To-Present-on-December-3rd-2024-at-the-Piper-Sandler-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","TECX","BK4137","BK4139"],"gpt_icon":0},{"id":"2484111828","title":"Raymond James Initiates Tectonic Therapeutic at Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2484111828","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484111828?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:47","pubTimestamp":1732110435,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic (TECX) has an average rating of buy and mean price target of $72.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RJF","TECX"],"gpt_icon":0},{"id":"2484118350","title":"Tectonic Therapeutic Inc : Raymond James Initiates Coverage With Outperform Rating; Target Price $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2484118350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484118350?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:39","pubTimestamp":1732106380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nFWN3MR0A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2483382814","title":"Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483382814?lang=en_us&edition=fundamental","pubTime":"2024-11-14 14:01","pubTimestamp":1731564067,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc (TECX) has disclosed a new risk, in the Innovation / R&D category. Tectonic Therapeutic Inc. faces a significant risk rela...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tectonic-therapeutic-inc-faces-challenges-with-australian-subsidiary-amid-regulatory-and-operational-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tectonic-therapeutic-inc-faces-challenges-with-australian-subsidiary-amid-regulatory-and-operational-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2483017943","title":"Tectonic Therapeutic Inc. Reports Q3 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483017943","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483017943?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:01","pubTimestamp":1731470468,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc  has released its Q3 earnings. Here is a breakdown of the information Tectonic Therapeutic Inc presented to its investors.Tectonic Therapeutic Inc., based in Watertown, Massachusetts, is a clinical-stage biotechnology company specializing in the development of therapeutic proteins and antibodies targeting G-protein coupled receptors  to address unmet medical needs. Tectonic recently announced its third-quarter 2024 financial results, highlighting significant advancements in its clinical pipeline, including ongoing trials and a strong cash position.The company has made remarkable progress in its clinical trials, with patient enrollment in the Phase 1b hemodynamic trial exceeding expectations and the APEX Phase 2 clinical trial for its lead program, TX45, underway. Additionally, Tectonic selected TX2100 as the development candidate for its second program targeting Hereditary Hemorrhagic Telangiectasia , a genetic bleeding disorder with no approved therapies.Tesla","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VfFShRbSXeKd1NWnCc3B2Q--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/5c9a5f191a1b61dffcdf2f63fbd4912c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VfFShRbSXeKd1NWnCc3B2Q--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/5c9a5f191a1b61dffcdf2f63fbd4912c"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/tectonic-therapeutic-inc-reports-q3-040108955.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tectonic-therapeutic-inc-reports-q3-040108955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2482085851","title":"Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085851","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482085851?lang=en_us&edition=fundamental","pubTime":"2024-11-12 19:52","pubTimestamp":1731412369,"startTime":"0","endTime":"0","summary":"Key Insights Insiders appear to have a vested interest in Tectonic Therapeutic's growth, as seen by their sizeable...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tecx/tectonic-therapeutic/news/insiders-of-tectonic-therapeutic-inc-nasdaqtecx-were-rewarde","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TQQQ","IE00B3QW5Z07.USD","QID","LU2095319765.USD","MNQmain","IE00B64PRP62.GBP","NQmain","QLD","LU2210150020.SGD","PSQ","NDAQ","BK4585",".IXIC","BK4112","BK4139","BK4588","IE00BKPKM429.USD","LU2210149790.SGD","TECX","IE00BGHQF748.EUR","SQQQ"],"gpt_icon":1}],"pageSize":16,"totalPage":3,"pageCount":2,"totalSize":46}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TECX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"TECX","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2024-08-14","symbol":"TECX","fiscalQuarterEnding":"2024/06","expectedEps":-1.96,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-3.81},{"market":"US","date":"2024-06-21","symbol":"TECX","defaultRemindTime":1718976600000,"type":"split","dateTimestamp":1718942400000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TECX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TECX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1732075200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TECX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TECX","date":"2025-03-28","current":-6.086564,"percent":0.757225,"low":-15.128417,"twenty":-12.89943,"median":-9.616813,"eighty":-5.925952,"high":-5.226133,"avg":-9.400433,"sd":3.197316,"marketCap":352911127},"quantilePoints":[{"date":"2024-06-28","current":-5.572811,"twenty":-5.572811,"median":-5.572811,"eighty":-5.572811,"marketCap":242968986},{"date":"2024-07-05","current":-5.30076,"twenty":-5.567404,"median":-5.37342,"eighty":-5.30076,"marketCap":231107856},{"date":"2024-07-12","current":-5.555913,"twenty":-5.557941,"median":-5.380179,"eighty":-5.318334,"marketCap":242232270},{"date":"2024-07-15","current":-5.724889,"twenty":-5.566052,"median":-5.386938,"eighty":-5.322727,"marketCap":249599431},{"date":"2024-08-02","current":-6.005389,"twenty":-5.571459,"median":-5.412285,"eighty":-5.328134,"marketCap":261828955},{"date":"2024-08-09","current":-5.542396,"twenty":-5.687715,"median":-5.542396,"eighty":-5.354494,"marketCap":241642930},{"date":"2024-08-16","current":-5.435122,"twenty":-5.578219,"median":-5.468047,"eighty":-5.376124,"marketCap":249010092},{"date":"2024-08-23","current":-5.531661,"twenty":-5.571459,"median":-5.454529,"eighty":-5.368797,"marketCap":253433038},{"date":"2024-08-30","current":-6.110556,"twenty":-5.781665,"median":-5.503532,"eighty":-5.376124,"marketCap":279955101},{"date":"2024-09-06","current":-5.875782,"twenty":-5.972264,"median":-5.537028,"eighty":-5.386938,"marketCap":269198931},{"date":"2024-09-13","current":-5.628143,"twenty":-5.904726,"median":-5.566052,"eighty":-5.419098,"marketCap":257853382},{"date":"2024-09-20","current":-6.367842,"twenty":-5.997993,"median":-5.603857,"eighty":-5.427493,"marketCap":291742684},{"date":"2024-09-27","current":-9.191562,"twenty":-6.110556,"median":-5.628143,"eighty":-5.435122,"marketCap":421111409},{"date":"2024-10-04","current":-9.545331,"twenty":-6.174877,"median":-5.71982,"eighty":-5.437631,"marketCap":437319336},{"date":"2024-10-11","current":-9.969854,"twenty":-7.795782,"median":-5.795859,"eighty":-5.451149,"marketCap":456768849},{"date":"2024-10-18","current":-11.555382,"twenty":-9.545331,"median":-5.890254,"eighty":-5.454529,"marketCap":529409830},{"date":"2024-10-25","current":-11.706538,"twenty":-9.969854,"median":-5.972264,"eighty":-5.473714,"marketCap":536335035},{"date":"2024-10-31","current":-13.205232,"twenty":-10.302396,"median":-6.005389,"eighty":-5.479995,"marketCap":604997707},{"date":"2024-11-08","current":-14.578499,"twenty":-10.949472,"median":-6.102515,"eighty":-5.516712,"marketCap":667913933},{"date":"2024-11-15","current":-11.919174,"twenty":-11.683382,"median":-6.165229,"eighty":-5.530429,"marketCap":637413561},{"date":"2024-11-22","current":-12.383564,"twenty":-11.738699,"median":-6.271359,"eighty":-5.540249,"marketCap":662248209},{"date":"2024-11-29","current":-13.732542,"twenty":-12.061704,"median":-6.592968,"eighty":-5.550506,"marketCap":734388858},{"date":"2024-12-06","current":-14.140821,"twenty":-12.551724,"median":-9.005029,"eighty":-5.561996,"marketCap":756222838},{"date":"2024-12-13","current":-12.789085,"twenty":-12.985735,"median":-9.500306,"eighty":-5.570107,"marketCap":683934662},{"date":"2024-12-20","current":-12.154596,"twenty":-12.971537,"median":-9.744728,"eighty":-5.576867,"marketCap":650003477},{"date":"2024-12-27","current":-14.124269,"twenty":-13.152703,"median":-9.969854,"eighty":-5.599,"marketCap":755337676},{"date":"2025-01-03","current":-12.604255,"twenty":-13.140244,"median":-10.085633,"eighty":-5.628143,"marketCap":674050360},{"date":"2025-01-10","current":-12.102182,"twenty":-13.156277,"median":-10.423321,"eighty":-5.628143,"marketCap":647200466},{"date":"2025-01-17","current":-11.591832,"twenty":-13.147343,"median":-10.551179,"eighty":-5.628143,"marketCap":619907991},{"date":"2025-01-24","current":-11.641488,"twenty":-13.118945,"median":-10.789946,"eighty":-5.669309,"marketCap":622563475},{"date":"2025-01-31","current":-15.128417,"twenty":-13.118945,"median":-10.854276,"eighty":-5.707721,"marketCap":809037464},{"date":"2025-02-07","current":-11.751833,"twenty":-13.160922,"median":-11.088711,"eighty":-5.722861,"marketCap":628464551},{"date":"2025-02-14","current":-9.495261,"twenty":-13.14913,"median":-10.854276,"eighty":-5.773563,"marketCap":507787555},{"date":"2025-02-21","current":-8.506286,"twenty":-13.126045,"median":-10.619502,"eighty":-5.791808,"marketCap":454899165},{"date":"2025-02-28","current":-7.053859,"twenty":-13.096949,"median":-10.42964,"eighty":-5.830305,"marketCap":377226257},{"date":"2025-03-07","current":-6.264886,"twenty":-13.019156,"median":-10.085633,"eighty":-5.866777,"marketCap":335033567},{"date":"2025-03-14","current":-6.485578,"twenty":-12.9375,"median":-9.998798,"eighty":-5.877518,"marketCap":346835718},{"date":"2025-03-21","current":-6.118678,"twenty":-12.909913,"median":-9.812505,"eighty":-5.894306,"marketCap":327214642},{"date":"2025-03-28","current":-6.086564,"twenty":-12.89943,"median":-9.616813,"eighty":-5.925952,"marketCap":352911127}],"updateTime":1743424564290}}}